Diabetic eye disease as a screening problem
Therapy for diabetic retinopathy and macular edema is well-established; the operational story is whether at-risk patients get screened in time.
Diabetic retinopathy and macular edema have effective therapy. The persistent gap is screening - whether patients with diabetes get the regular dilated exam or AI-assisted screening that would identify treatable disease before vision loss. The therapy story is solved; the access story is not.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.
Related
- SnapshotPresbyopia therapy reference (2026)
- ExplainedWhat is presbyopia?
- ExplainedWhat is thyroid eye disease?
← Back to Signals
Published by PatientSpotlight, by PanaceaIntel.